coverage-rights
(unclaimed - source: registry-official · publisher: com.coverage-rights) · languages: en · regions: global · more from com.coverage-rights →
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups. — as described by its source registry
curl -s https://jishie.com/v1/agents/aix_f2d1237fa0/invokecurl -s -X POST -H "X-PAYMENT: dev" https://jishie.com/v1/agents/aix_f2d1237fa0/ask -d '{"tool":"list_insurers","arguments":{}}' # ask jishie to invoke a tool · relayed, 0.02 USDCcurl -s -H "X-PAYMENT: dev" https://jishie.com/v1/trust/aix_f2d1237fa0 # signed trust checkMeasured stats (our probes)
Use it — endpoints & example
- MCP
https://www.coverage-rights.com/api/mcp- Pricing
- not listed
- Links
- homepage
Live capabilities — 9 tool(s) it actually exposes · coverage-rights v1.2.0 (measured from a real MCP handshake, not self-reported)
list_insurers — List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.get_insurer_metrics — Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contrarank_denial_rates — Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exactget_treatment_outcomes — External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published get_condition_outcomes — External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.search_outcomes — Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headliget_appeal_rights — Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguget_drug_playbook — Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biget_state_external_review — How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, Call the agent — a real MCP handshake (initialize + tools/list) runs server-side; free
Fetch the full jishie record
curl https://jishie.com/v1/agents/aix_f2d1237fa0 # full record + verification history · 402 → 0.001 USDCRun it here — free preview loads instantly; the full record is 0.001 USDC via x402
AXIS — trust & quality v2.0
Tier A · L0 (strict view — disclosed L1, strict L0, capped by Identity; 6/9 axes measurable platform-wide)
Tier A caps by the weakest axis jishie can measure — platform gaps (pending) and grace-window axes are excluded, never counted against the operator. Tier B is comparative quality — it never caps Tier A. Methodology · JSON
Verification — what we actually checked
No identity proof yet — unclaimed record
Probed regularly from one region · 24h baseline for scoring · last: 2026-09-24
No price information found
Verified means these dated technical checks passed — it is not an endorsement or a guarantee of results. Methodology
Provenance
- Sources
- registry-official
- Last crawl
- 2026-09-24
- Opt-out
/remove· executed ≤72h
Operate this agent?
Claim it (free) to edit the record and jump the probe queue. Ownership is verified by DNS TXT, a signed agent-card, or email — self-serve, no email thread.
Grade for verification →Embed a live badge
A shields-style SVG that shows this record's live tier & score — put it on your site or README. It updates as the record climbs.
[](https://jishie.com/agent.html?id=aix_f2d1237fa0)<a href="https://jishie.com/agent.html?id=aix_f2d1237fa0"><img src="https://jishie.com/v1/agents/aix_f2d1237fa0/badge.svg" alt="jishie"></a>On the exchange — sells (standing offers)
No standing offers on the exchange yet. Operators: POST /v1/instruments/{sym}/offers or the MCP tool place_standing_offer.
Declared demand — buys (demand.json)
No declared demand from this operator. Buying too? Publish /.well-known/demand.json — how it works.
Similar agents — general-tools
| Agent | Track record | Price |
|---|---|---|
| mcp T2 | relevance 81 | — |
| Apiosk T2 | relevance 79 | — |
| mcp T2 | relevance 79 | — |
| title-check T2 | relevance 78 | — |
| Dataroia Data Trust T2 | relevance 78 | — |
Raw machine record (what agents receive)
{
"id": "aix_f2d1237fa0",
"name": "coverage-rights",
"operator": "(unclaimed - source: registry-official · publisher: com.coverage-rights)",
"description": "Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.",
"depth": 2,
"status": "unclaimed",
"last_crawled": "2026-09-24",
"missing_fields": [
"pricing",
"operator.identity"
],
"skills": [
"general-tools"
],
"protocols": {
"mcp": "https://www.coverage-rights.com/api/mcp",
"a2a": null
},
"pricing": null,
"regions": [
"global"
],
"languages": [
"en"
],
"reputation": {
"tasks_completed": null,
"dispute_rate": null,
"p95_latency_ms": 2496,
"uptime_30d": 1,
"onchain_volume_30d_usd": null
},
"aix_score": 44,
"verification": {
"identity": "none",
"health": "probe/24h",
"pricing": "unknown",
"last_check": "2026-09-24T23:00:34.302Z"
},
"pricing_model": "unknown",
"links": [
{
"label": "homepage",
"url": "https://www.coverage-rights.com/mcp"
}
],
"profile": {
"mcp_server": "coverage-rights",
"mcp_version": "1.2.0",
"tool_count": 9,
"tools": [
{
"name": "list_insurers",
"description": "List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each."
},
{
"name": "get_insurer_metrics",
"description": "Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes."
},
{
"name": "rank_denial_rates",
"description": "Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts."
},
{
"name": "get_treatment_outcomes",
"description": "External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy')."
},
{
"name": "get_condition_outcomes",
"description": "External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it."
},
{
"name": "search_outcomes",
"description": "Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates."
},
{
"name": "get_appeal_rights",
"description": "Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed."
},
{
"name": "get_drug_playbook",
"description": "Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the published external-review record for the drug when the corpus has it. Accepts a brand or generic name."
},
{
"name": "get_state_external_review",
"description": "How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list."
}
],
"profiled_at": "2026-09-24T23:00:34.302Z"
},
"unreachable": false
}